“ACHILLES” Heel No More? Afatinib at 40 Mg Once Daily is Superior to Platinum-Based Chemotherapy in EGFR Uncommon (G719X,...
Introduction The three “uncommon” epidermal growth factor receptor (EGFR) mutations (G719X, S768I, and L861Q) were discovered in the same year as the canonical activating EGFR mutations in 2004.1,2 Given the incidence of these three “uncommon” mutations …